Fresenius Kabi is looking for in-licensing opportunities in infusion therapy and clinical nutrition, e.g. in the area of i.v. drugs, more specifically in the areas of pain management/CNS, anesthesia, anti-infectives, inflammation and oncology. More
APR is interested to in-license new early stage, innovative and patent protected products/technologies (preferably off patent or close to expiry) for oral, topical or transdermal administration More